KAT Innovation is developing a first-in-class Precision Bone Bioelectronics™ Platform, a scalable technology ecosystem designed to support multiple products, therapeutic indications, and future generations of wearable bioelectronic therapies for skeletal health. The Platform integrates proprietary bioelectronic stimulation technologies, wearable medical electronics, smart textile systems, computational modelling, clinical science, connected digital health capabilities, and intellectual property within a common technological foundation.
Founded on a genuine passion for innovation and a deeply personal motivation, KAT Innovation is dedicated to designing and realizing technologies that can change lives. Marcel Maroist, CEO and founder, is a dynamic and committed entrepreneur with extensive experience in health, fitness, and sports, whose own family's experience with osteoporosis first revealed the need for a better solution. His expertise has enabled him to assemble a multidisciplinary team of seasoned professionals, and KAT Innovation aspires to lead the medical and healthcare technology industry with advanced solutions that enhance health outcomes and streamline the work of medical professionals.
The Platform's first intended commercial application, OSTAAT™ (One Stimulation At A Time), is being developed as a smart wearable medical device initially targeting women aged 50 and over who are newly diagnosed with osteoporosis. The lead application is focused on the hip, one of the most clinically significant anatomical sites for fragility fractures, disability, loss of independence, and healthcare expenditure.
To design a connected, effective, and state-of-the-art platform, KAT Innovation prioritizes international collaboration. Since its inception, the company has expanded globally, establishing KAT Innovation Canada (Montreal), KAT Innovation France (Paris), KAT Innovation Technologies Spain (Malaga), KAT Innovation USA (Chicago / Beverly Hills), and soon KAT Innovation UK Ltd.
At KAT Innovation, our mission is to develop clinically validated Precision Bone Bioelectronics™ technologies that improve bone health, reduce fracture risk and empower people to live fully, preserving their mobility, independence and quality of life.
KAT Innovation aspires to be the world's defining force in Precision Bone Bioelectronics™, redefining how the world prevents and manages bone fragility through clinically validated, non-invasive therapies.
Marcel Maroist, CEO, and founder of KAT Innovation, brings over four decades of extensive experience in corporate management and event organization across diverse sectors. His career began with ownership of a paramedical clinic in Quebec City, followed by management of a sports medicine center in Montreal's North Shore. Passionate about physical activity and health, Marcel has practiced martial arts since age 12, achieving the prestigious rank of 8th-degree black belt Taekwondo Grandmaster and establishing more than fifteen Taekwondo schools globally.
With a background in physical education and a profound commitment to sports and health, Marcel devoted over 13 years to health research, leading and funding the development of medical devices and overseeing clinical trials. His expertise spans from research and development to the commercialization of innovative healthcare solutions.
Since 2011, Marcel has integrated his medical research expertise with martial arts principles of resilience, perseverance, and tenacity. Alongside his professional endeavors, he maintains a fervent enthusiasm for sports and health.
Today, he leads KAT Innovation with a strong commitment to innovation in healthcare and achieving excellence in management, exerting influence across North America, Europe, Australia and Asia.
Our multidisciplinary team brings together experts from various backgrounds, including electrical and biomedical engineers, kinesiologists, physiologists, and biologists, all under the enlightened leadership of our CEO-Founder and supported by our scientific advisors. This strategic combination of skills ensures a strong position on the path to success.
For nearly 4 years, we have had the privilege of collaborating with distinguished scientific advisors, including physicians, both in Quebec and abroad.
The list of physicians and hospitals eager to participate in our project is impressive: rheumatologists, orthopedists, geriatricians, and nephrologists from prestigious institutions such as the University of Montreal Health Centre (CHUM), CHU of Bordeaux, Limoges, and Poitiers in France, University Hospitals of Malaga and Granada in Spain, Mongi Slim Hospital in Tunis, and the Osteoporosis Medical Center in Los Angeles (UCLA Health-Cedars Sinai Hospital).
These experts play a crucial role in guiding and advising us, significantly contributing to all phases of our studies, from pilot studies to preclinical animal studies, including a multicenter study involving this extensive international team of physicians.
Loading team members...
Sustainability is a fundamental principle ingrained across OSTAAT™'s design and operations. We aim to deliver world-class osteoporosis therapy while minimizing environmental impact through the following initiatives:
Our conductive polymer electrodes improve energy efficiency and reduce battery usage by 20% compared to competitors.
In the next 5 years, we aim to have over 85% recyclability in our medical garments and hardware using bioplastics.
We partner with suppliers adhering to top sustainability standards, including renewable energy, ethical labor, and wastewater treatment, with a focus on ISO 14001 certification.
By centralizing fulfillment and optimizing kitting for our products, we have reduced shipping emissions by a margin of over 30%.
Loading partners...
